The synthetic β-nitrostyrene derivative CYT-Rx20 induced breast cancer cell death.
CYT-Rx20 induced breast cancer cell death via ROS and MEK/ERK regulation.
CYT-Rx20 induced autophagy in breast cancer cells.
CYT-Rx20 induced autophagy via ROS and MEK/ERK regulation.
CYT-Rx20 inhibited orthotopic tumor growth in vivo.